| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PKBO | Common Stock | Other | $0 | +6,442,438 | $0.000000 | 6,422,438 | 01 Nov 2022 | Direct | F1 | |
| transaction | PKBO | Common Stock | Other | $0 | +372,562 | +413958% | $0.000000 | 372,652 | 01 Nov 2022 | See footnote | F1, F2 |
| Id | Content |
|---|---|
| F1 | Received pursuant to the consummation of the transactions contemplated by that certain Business Combination Agreement between Ignyte Acquisition Corp. (the former name of the Issuer), a Delaware corporation, Peak Bio Co., Ltd., a corporation organized under the laws of the Republic of Korea, and Ignyte Korea Co., Ltd., a corporation organized under the laws of the Republic of Korea. |
| F2 | The securities are held by Hannol Ventures LLC (the "LLC"). The Reporting Person is sole member of the LLC. |